SHEFALI AGARWAL
Profile
First Name
: SHEFALI
Middle Name
:
Last Name
: AGARWAL
Related Companies
Titles
Company Name
Related People
DIRECTOR
STEWART ABBOT, TIMOTHY COUGHLIN, TIMOTHY P. COUGHLIN, MARK ENYEDY, MARK J. ENYEDY, ROBERT EPSTEIN, ROBERT S. EPSTEIN, PAUL GRAYSON, ROBERT HERSHBERG, KARIN JOOSS, MICHAEL LEE, JOHN MENDLEIN, AMIR NASHAT, ROBERT NELSEN, ROBERT T. NELSEN, WILLIAM RASTETTER, BRYAN ROBERTS, BRYAN E. ROBERTS, DANIEL SHOEMAKER, DANIEL D. SHOEMAKER, CHRIS STORGARD, CINDY TAHL, CARL WEISSMAN, CHRISTIAN WEYER, J. SCOTT WOLCHKO, SCOTT WOLCHKO
DIRECTOR
SHEFALI AGARWAL, M.D., M.P.H., ANDREW ALLEN, ANDREW ALLEN, M.D., PH.D., JAMES CHO, LAWRENCE COREY, CELIA ECONOMIDES, VASSILIKI ECONOMIDES, CLARE FISHER, MATT HAWRYLUK, MATTHEW HAWRYLUK, RICHARD HEYMAN, PH.D., ELAINE JONES, ERIN JONES, ERIN E. JONES, ELAINE JONES, PH.D., KARIN JOOS, STEVE KROGNES, JUDITH LI, NAIYER A. RIZVI, NAIYER RIZVI, M.D., RAHSAAN THOMPSON, J.D.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2022-10-24
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2020-06-24
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2020-04-07
